No Data
No Data
Medirex, HYUGA PRIMARY CARE, etc.
<205A> Logos Holdings Co., Ltd., Yuoichi Ikeda's shareholding ratio - % → 9.05%. Reporting obligation date: June 28, 2024. <205A> Logos Holdings Co., Ltd., Endeavor United Corporation's shareholding ratio - % → 53.86%. Reporting obligation date: June 28, 2024. <206A> Prism BioLab Co., Ltd., Yoshiichiro Nakashima's shareholding ratio - % → 5.29%. Reporting obligation.
Insider decrases its stake in AnGes(4563.JP) to 7.19%
On Jul 8, CANTOR FITZGERALD EUROPE submitted the Change Report to Ministry of Finance. The report shows that CANTOR FITZGERALD EUROPE decreased their holdings in $AnGes(4563.JP)$, with their joint sha
Change in the development and sales strategy of Anges - HGF gene therapy product "Collategene".
On the 24th, Anges announced a change in the development and sales strategy of its HGF gene therapy product "Collategene." The late-phase 2 clinical trial (February 2020-March 2023) for Collategene, targeting mild to moderate atherosclerosis with lower limb ulcers in the United States, has been completed with good results. Based on these results, the previous approval for severe patients only with conditional and time-limited approval will be temporarily withdrawn and will now be applicable to patients with various degrees of atherosclerosis.
Chordia Therapeutics, Yapri, etc.
Holder percentage of Yo Miyake's share in Chordia Therapeutics Inc. stock is 5.73%, report obligation day on June 14, 2024. Holder percentage of Mitsubishi UFJ Capital Co., Ltd. (group name) Mitsubishi UFJ Life Sciences No. 1 Investment Business Limited Liability Partnership's share in Chordia Therapeutics Inc. stock is 6.07%, report obligation day on June 14, 2024.
Brackets, Best One Dotcom, etc.
<4166> KAKKO CO., LTD. SBI Investment Co., Ltd. shareholding ratio 5.01% → 4.78%, reporting obligation arise on June 12, 2024. <4199> Wonderplanet Inc. Atsushi Ishikawa shareholding ratio 10.47% → 8.91%, reporting obligation arise on May 1, 2024. <4199> Wonderplanet, Inc. Yuki Tokikawa shareholding ratio 17.14% → 15.38%, reporting obligation arise on 20.
Kids' Bio, Cringle, and others.
<2997> Implementation of the Storage King shareholder benefits and introduction of shareholder benefit system <4563> Ange's 44th new share subscription right (with exercise price adjustment clause) Large-scale exercise of subscription rights, 3.9 million shares delivered from the 18th <4584> Kids Bio Caiohm Biosciences <4583> Signed a business alliance agreement for the joint development of new biosimilars <4882> Perseus large-scale exercise of the 28th new share subscription right (with exercise price adjustment clause), 370,200 shares delivered from the 14th.
No Data